Idhifa
enasidenib mesylate
- Strength
- 100 mg/1
- Form
- Tablet, Film Coated
- Class
- Isocitrate Dehydrogenase 2 Inhibitor
Celgene Corporation
Not stocked by us — reference only
enasidenib mesylate
Listed by Celgene Corporation
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Isocitrate Dehydrogenase 2 Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 59572-705 |
| FDA application | NDA209606 |
| RxNorm concept | 1940370 |
| Package sizes listed | 1 |
| Marketed since | August 2017 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
enasidenib mesylate
Celgene Corporation
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.